288 related articles for article (PubMed ID: 19182698)
1. MF101, a selective estrogen receptor beta modulator for the treatment of menopausal hot flushes: a phase II clinical trial.
Grady D; Sawaya GF; Johnson KC; Koltun W; Hess R; Vittinghoff E; Kristof M; Tagliaferri M; Cohen I; Ensrud KE
Menopause; 2009; 16(3):458-65. PubMed ID: 19182698
[TBL] [Abstract][Full Text] [Related]
2. Predictors of hot flushes in postmenopausal women who receive raloxifene therapy.
Aldrighi JM; Quail DC; Levy-Frebault J; Aguas F; Kosian K; Garrido L; Bosio-Le Goux B; Saráchaga M; Graebe A; Niño AJ; Nickelsen T
Am J Obstet Gynecol; 2004 Dec; 191(6):1979-88. PubMed ID: 15592280
[TBL] [Abstract][Full Text] [Related]
3. Femal, a herbal remedy made from pollen extracts, reduces hot flushes and improves quality of life in menopausal women: a randomized, placebo-controlled, parallel study.
Winther K; Rein E; Hedman C
Climacteric; 2005 Jun; 8(2):162-70. PubMed ID: 16096172
[TBL] [Abstract][Full Text] [Related]
4. Clinically meaningful efficacy of a non-estrogen agent: re-analysis of phase-2 data evaluating MF101.
Tagliaferri M; Creasman J; Caygill KA; Olyaie A; Leitman D; Cohen I; Grady D
Climacteric; 2012 Dec; 15(6):607-10. PubMed ID: 22257013
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and tolerability of desvenlafaxine succinate treatment for menopausal vasomotor symptoms: a randomized controlled trial.
Speroff L; Gass M; Constantine G; Olivier S;
Obstet Gynecol; 2008 Jan; 111(1):77-87. PubMed ID: 18165395
[TBL] [Abstract][Full Text] [Related]
6. Tissue-selective agents: selective estrogen receptor modulators and the tissue-selective estrogen complex.
Pickar JH; Mirkin S
Menopause Int; 2010 Sep; 16(3):121-8. PubMed ID: 20956688
[TBL] [Abstract][Full Text] [Related]
7. Raloxifene is not associated with biologically relevant changes in hot flushes in postmenopausal women for whom therapy is appropriate.
Palacios S; Farias ML; Luebbert H; Gomez G; Yabur JA; Quail DC; Turbi C; Kayath MJ; Almeida MJ; Mönnig E; Nickelsen T
Am J Obstet Gynecol; 2004 Jul; 191(1):121-31. PubMed ID: 15295352
[TBL] [Abstract][Full Text] [Related]
8. Lowest effective transdermal 17beta-estradiol dose for relief of hot flushes in postmenopausal women: a randomized controlled trial.
Bachmann GA; Schaefers M; Uddin A; Utian WH
Obstet Gynecol; 2007 Oct; 110(4):771-9. PubMed ID: 17906008
[TBL] [Abstract][Full Text] [Related]
9. Bazedoxifene/conjugated estrogens and quality of life in postmenopausal women.
Utian W; Yu H; Bobula J; Mirkin S; Olivier S; Pickar JH
Maturitas; 2009 Aug; 63(4):329-35. PubMed ID: 19647382
[TBL] [Abstract][Full Text] [Related]
10. Effect of raloxifene and low-dose percutaneous 17beta-estradiol on menopause symptoms and endometrium--a randomized controlled trial.
Valiati B; Capp E; Edelweiss MI; de Freitas FM; Wender MC
Maturitas; 2009 Jan; 62(1):81-4. PubMed ID: 19097715
[TBL] [Abstract][Full Text] [Related]
11. MF101: a multi-component botanical selective estrogen receptor beta modulator for the treatment of menopausal vasomotor symptoms.
Leitman DC; Christians U
Expert Opin Investig Drugs; 2012 Jul; 21(7):1031-42. PubMed ID: 22616988
[TBL] [Abstract][Full Text] [Related]
12. Effects of the phytoestrogen genistein on hot flushes, endometrium, and vaginal epithelium in postmenopausal women: a 2-year randomized, double-blind, placebo-controlled study.
D'Anna R; Cannata ML; Marini H; Atteritano M; Cancellieri F; Corrado F; Triolo O; Rizzo P; Russo S; Gaudio A; Frisina N; Bitto A; Polito F; Minutoli L; Altavilla D; Adamo EB; Squadrito F
Menopause; 2009; 16(2):301-6. PubMed ID: 19034051
[TBL] [Abstract][Full Text] [Related]
13. First time proof of sage's tolerability and efficacy in menopausal women with hot flushes.
Bommer S; Klein P; Suter A
Adv Ther; 2011 Jun; 28(6):490-500. PubMed ID: 21630133
[TBL] [Abstract][Full Text] [Related]
14. Vaginal, endometrial, and reproductive hormone findings: randomized, placebo-controlled trial of black cohosh, multibotanical herbs, and dietary soy for vasomotor symptoms: the Herbal Alternatives for Menopause (HALT) Study.
Reed SD; Newton KM; LaCroix AZ; Grothaus LC; Grieco VS; Ehrlich K
Menopause; 2008; 15(1):51-8. PubMed ID: 18257142
[TBL] [Abstract][Full Text] [Related]
15. Long-term efficacy and safety of the special extract ERr 731 of Rheum rhaponticum in perimenopausal women with menopausal symptoms.
Hasper I; Ventskovskiy BM; Rettenberger R; Heger PW; Riley DS; Kaszkin-Bettag M
Menopause; 2009; 16(1):117-31. PubMed ID: 18978638
[TBL] [Abstract][Full Text] [Related]
16. Relief of hot flushes with new plant-derived 10-component synthetic conjugated estrogens.
Utian WH; Lederman SA; Williams BM; Vega RY; Koltun WD; Leonard TW
Obstet Gynecol; 2004 Feb; 103(2):245-53. PubMed ID: 14754691
[TBL] [Abstract][Full Text] [Related]
17. Effects of the phytoestrogen genistein on hot flushes, endometrium, and vaginal epithelium in postmenopausal women: a 1-year randomized, double-blind, placebo-controlled study.
D'Anna R; Cannata ML; Atteritano M; Cancellieri F; Corrado F; Baviera G; Triolo O; Antico F; Gaudio A; Frisina N; Bitto A; Polito F; Minutoli L; Altavilla D; Marini H; Squadrito F
Menopause; 2007; 14(4):648-55. PubMed ID: 17251874
[TBL] [Abstract][Full Text] [Related]
18. Effects of bazedoxifene in nonflushing postmenopausal women: a randomized phase 2 trial.
Bachmann G; Crosby U; Feldman RA; Ronkin S; Constantine GD
Menopause; 2011 May; 18(5):508-14. PubMed ID: 21289525
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of a soy isoflavone extract in postmenopausal women: a randomized, double-blind, and placebo-controlled study.
Nahas EA; Nahas-Neto J; Orsatti FL; Carvalho EP; Oliveira ML; Dias R
Maturitas; 2007 Nov; 58(3):249-58. PubMed ID: 17913408
[TBL] [Abstract][Full Text] [Related]
20. Is a shorter hot flash diary just as good as a 7-day diary?
Grady D; Macer J; Kristof M; Shen H; Tagliaferri M; Creasman J
Menopause; 2009; 16(5):932-6. PubMed ID: 19421075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
